IP Library Granted Patent US 7,867,728
Granted Patent B2
US 7,867,728 · App. 11/660,250 · Granted Jan 11, 2011

Determining the concentration of analytes in sample by direct mediation of enzymes

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,867,728
App. No.
11/660,250
Granted
Jan 11, 2011
Kind
B2
Abstract

The glucose content of blood can be determined by contacting a blood sample with a test strip containing a glucose dehydrogenase dependent on PQQ (or derivatives or isomers) thereof as a co-factor, a tetrazolium salt indicator, but in the absence of a mediator.

Claims (30)

1. A reagent for measuring the concentration of glucose in blood comprising:

(a) a glucose dehydrogenase (GDH);

(b) as a co-factor for GDH, pyrrolo-quinoline quinone (PQQ) or a PQQ derivative or isomer, said GDH and co-factor being capable of reducing to a colored formazan a tetrazolium salt indicator in the absence of a separate mediator; and

(c) a tetrazolium salt indicator.

2. A reagent of claim 1 , wherein said glucose dehydrogenase of (a) is classified according to International Union of Biochemistry and Molecular Biology; Nomenclature and Classification of Enzyme-Catalyzed Reactions (i.e., NC-IUBMB) as EC1.1.99.17 (now EC1.1.5.2).

3. A reagent of claim 1 , wherein said co-factor is PQQ.

4. A reagent of claim 1 , wherein said co-factor is a PQQ derivative or isomer.

5. A reagent of claim 1 , wherein said tetrazolium salt indicator is WST-4.

6. A reagent of claim 1 , wherein said tetrazolium salt indicator is an analog of HTC-45.

7. A test strips for measuring the glucose in blood comprising:

(a) a support;

(b) a reagent layer disposed on said support, said reagent system comprising;

(1) a glucose dehydrogenase (GDH);

(2) as a co-factor for GDH, pyrrolo-quinoline quinone (PQQ) or a PQQ derivative or isomer, said GDH and co-factor being capable of reducing to a colored formazan a tetrazolium salt indicator in the absence of a separate mediator; and

(3) a tetrazolium salt indicator.

8. A test strip of claim 7 , wherein said glucose dehydrogenase of (b) (1) is classified according to NC-IUBMB as EC1.1.99.17 (now EC1.1.5.2).

9. A test strip of claim 7 , wherein said co-factor is PQQ.

10. A test strip of claim 7 , wherein said co-factor is a PQQ derivative or isomer.

11. A test strip of claim 7 , wherein said tetrazolium salt indicator is WST-4.

12. A test strip of claim 7 , wherein said tetrazolium salt indicator is an analog of HTC-45.

13. A method for measuring glucose in blood comprising:

(a) a support;

(b) a reagent system disposed on said support, said reagent system comprising a glucose dehydrogenase (GDH), as a co-factor for GDH pyrrolo-quinoline quinono (PQQ) or a (PQQ) analog, said GDH and co-factor being capable of reducing a colored formazan a tetrazolium salt indicator in the absence of a separate mediator, and a tetrazolium salt indicator;

(c) measuring the color developed from said tetrazolium salt indicator; and

(d) correlating the color developed in step (b) with the glucose content of said blood sample.

14. The method of claim 13 , wherein said glucose dehydrogenase is classified as EC1.1.99.17.

15. The method of claim 13 , wherein said co-factor is PQQ.

16. The method of claim 13 , wherein said co-factor is a PQQ derivative or isomer.

17. The method of claim 13 , wherein said tetrazolium salt indicator is WST-4.

18. The method of claim 13 , wherein said tetrazolium salt indicator is an analog of HTC-45.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2016
From: BAYER HEALTHCARE LLC
To: ASCENSIA DIABETES CARE HOLDINGS AG
Reel/Frame 037880/0604 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2010
From: MARFURT, KAREN L.; WARCHAL-WINDHAM, MARY ELLEN
To: BAYER HEALTHCARE LLC
Reel/Frame 025542/0336 →